What seniors need to know about taking Paxlovid | CNN
CNN — A new coronavirus variant is circulating, the most transmissible one yet. Hospitalizations of infected patients are rising. And...
efficacy and availability
Report shares new details about death possibly linked to experimental Alzheimer’s drug | CNN
CNN — The death of a participant in a clinical trial of an antibody treatment for Alzheimer’s disease, which is...
FDA decision on experimental Alzheimer’s drug expected this week | CNN
CNN — The US Food and Drug Administration could decide this week whether to grant accelerated approval to the experimental...
How one mom headed off a drug shortage | CNN
CNN — Early this year, even before the national shortage of infant formula or a demand-driven shortfall of pain medications...
Dr. Sanjay Gupta: After two years of Covid-19 vaccines, here’s why they’re still vital | CNN
CNN — In the United States, approximately 658 million Covid-19 vaccine doses have been administered since they were first distributed...
Experimental mRNA cancer vaccine with immunotherapy reduces risk of melanoma returning, preliminary study finds | CNN
CNN — An experimental personalized mRNA vaccine in combination with the immunotherapy Keytruda reduced the risk of recurrence or death...
Empty pharmacy shelves shine a light on vulnerabilities in US drug supplies | CNN
CNN — Scarcity of several high-profile prescription drugs, such as the antibiotic amoxicillin and the ADHD treatment Adderall, have had...
Experimental drug appears to slow progression of Alzheimer’s disease in clinical trial but raises safety concerns | CNN
CNN — The experimental drug lecanemab shows “potential” as an Alzheimer’s disease treatment, according to new Phase 3 trial results,...
Shortages of antivirals, antibiotics compound stress of a rough season for viral illnesses in kids | CNN
CNN — Shortages of key medications used to treat common childhood illnesses like flu, ear infections and sore throats are...
After promising trial results for maternal RSV vaccine, Pfizer says it will seek FDA approval this year | CNN
CNN — Pfizer says it has enough promising data on its respiratory syncytial virus, or RSV, vaccine designed to protect...
